Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
International Immunopharmacology · 2025-05 · 154 · 114576
DOI: 10.1016/j.intimp.2025.114576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-05. Verfasst von Xiaomeng Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Neoplasms, Antigens, Neoplasm, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 170 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer-related deaths continue to rise, largely due to the suboptimal efficacy of current treatments. Fortunately, immunotherapy has emerged as a promising alternative, offering new hope for cancer patients. Among various immunotherapy approaches, targeting tumor-specific antigens (TSAs) has gained particular attention due to its demonstrated success in clinical settings. Despite these advancements, there are still gaps in our understanding of TSAs. Therefore, this review explores the life cycle of TSAs in cancer, the methods used to identify them, and recent advances in TSAs-targeted cancer therapies. Enhancing medical professionals' understanding of TSAs will help facilitate the development of more effective TSAs-based cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, X., Bai, J., Wang, X., Guo, S., Shang, Z., & Shao, Z. (2025). Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy. International Immunopharmacology, 154, 114576. https://doi.org/10.1016/j.intimp.2025.114576
Vancouver
Guo X, Bai J, Wang X, Guo S, Shang Z, Shao Z. Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy. International Immunopharmacology. 2025;154:114576. doi:10.1016/j.intimp.2025.114576
BibTeX
@article{Guo2025,
author = {Guo, Xiaomeng and Bai, Junqiang and Wang, Xinmiao and Guo, Shutian and Shang, Zhengjun and Shao, Zhe},
title = {Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy},
journal = {International Immunopharmacology},
year = {2025},
volume = {154},
pages = {114576},
doi = {10.1016/j.intimp.2025.114576}
}
EUVIMED